Krispy Kreme, Inc. current report, 08 February 2023

Krispy Kreme, Inc. — Form 8-K Summary

Business Context and Reporting Period

Filed February 8, 2023, under Item 5.02 and Item 9.01. The filing reports approval of standard equity award agreement forms under the Company’s 2021 Omnibus Incentive Plan. It does not report operating results for a specific financial period.

Financial and Operating Metrics

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.

Material Changes and Equity Arrangements

  • The Remuneration and Nomination Committee approved forms of restricted stock unit, performance-based restricted stock unit, and non-qualified stock option agreements.
  • Restricted stock units may be granted to directors and named executive officers. Vesting is generally 60% on the third anniversary, 20% on the fourth anniversary, and 20% on the fifth anniversary of the vesting commencement date, subject to continued service.
  • Performance-based restricted stock units may be granted to named executive officers and vest based on Committee-established dates, achievement of applicable performance goals, and continued service.
  • Non-qualified stock options may be granted to named executive officers and generally vest in full on the third anniversary of the agreement’s effective date, subject to continued service.

Outlook, Risks, and Unusual Items

No guidance, business outlook, material contingencies, or unusual operating items are disclosed. The principal conditions described are continued service requirements and, for performance-based awards, achievement of performance goals. The filing indicates that the detailed terms are contained in the filed agreement forms.

Investor Verification Items

  • Review Exhibits 10.1, 10.2, and 10.3 for the complete vesting, forfeiture, performance, and change-in-control provisions.
  • Verify the number, grant dates, valuation, and accounting expense of any awards subsequently issued under these forms.
  • Assess potential dilution and future share-based compensation expense from equity awards to directors and named executive officers.